{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:15:05Z","timestamp":1793661305680,"version":"4.5.1"},"reference-count":93,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Pheochromocytoma\/paraganglioma (PPGL) are neuroendocrine tumors that frequently produce and release catecholamines. Catecholamine excess can manifest in several cardiovascular syndromes, including cardiomyopathy. PPGL-induced cardiomyopathies occur in up to 11% of cases and are most often associated with an adrenal pheochromocytoma (90%) and rarely with a paraganglioma derived from the sympathetic ganglia (10%). PPGL-associated cardiomyopathies can be chronic or acute, with takotsubo cardiomyopathy being the most often reported. These two types of PPGL-induced cardiomyopathy seem to have different pathophysiological backgrounds. Acute catecholaminergic stress inundates myocardial \u03b2-adrenoceptors and leads to left ventricle stunning and slight histological apoptosis. In chronic cardiomyopathy, prolonged catecholamine exposure leads to extended myocardial fibrosis, inflammation, and necrosis, and ultimately it causes dilated cardiomyopathy with a low ejection fraction. Sometimes, especially in cases associated with hypertension, hypertrophic cardiomyopathy can develop. The prognosis appears to be worse in chronic cases with a higher hospital mortality rate, higher cardiogenic shock rate at initial presentation, and lower left ventricular recovery rate after surgery. Therefore, establishing the correct diagnosis at an early stage of a PPGL is essential. This mini-review summarizes current data on pathophysiological pathways of cardiac damage caused by catecholamines, the clinical presentation of PPGL-induced cardiomyopathies, and discusses treatment options.<\/jats:p>","DOI":"10.3389\/fendo.2023.1204851","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T15:45:10Z","timestamp":1689263110000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":49,"title":["Pheochromocytoma\/paraganglioma-associated cardiomyopathy"],"prefix":"10.3389","volume":"14","author":[{"given":"Alicja","family":"Szatko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Glinicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Gietka-Czernel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,7,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s12022-022-09704-6","article-title":"Overview of the 2022 who classification of paragangliomas and pheochromocytomas","volume":"33","author":"Mete","year":"2022","journal-title":"Endocr Pathol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.ejim.2018.01.015","article-title":"Incidence of pheochromocytoma and sympathetic paraganglioma in the Netherlands: a nationwide study and systematic review","volume":"51","author":"Berends","year":"2018","journal-title":"Eur J Intern Med"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.04.080","article-title":"Pathophysiology and acute management of tachyarrhythmias in pheochromocytoma: jacc review topic of the week","volume":"76","author":"Nazari","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.eprac.2022.09.003","article-title":"New biology of pheochromocytoma and paraganglioma","volume":"28","author":"Pacak","year":"2022","journal-title":"Endocr Pract"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1186\/s40200-016-0226-x","article-title":"Does this patient have pheochromocytoma? a systematic review of clinical signs and symptoms","volume":"15","author":"Soltani","year":"2015","journal-title":"J Diabetes Metab Disord"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1055\/a-0669-9556","article-title":"Catecholamine-induced cardiomyopathy in pheochromocytoma: how to manage a rare complication in a rare disease","volume":"51","author":"Santos","year":"2019","journal-title":"Horm Metab Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.ecl.2011.02.002","article-title":"Hypertension in pheochromocytoma: characteristics and treatment","volume":"40","author":"Zuber","year":"2011","journal-title":"Endocrinol Metab Clin North Am"},{"key":"B8","article-title":"Pheochromocytoma found in takotsubo cardiomyopathy patients","volume":"26","author":"Kobayashi","year":"2014","journal-title":"J Invasive Cardiol"},{"key":"B9","doi-asserted-by":"publisher","first-page":"76","DOI":"10.4250\/jcu.2011.19.2.76","article-title":"Prevalence and patterns of left ventricular dysfunction in patients with pheochromocytoma","volume":"19","author":"Park","year":"2011","journal-title":"J Cardiovasc Ultrasound"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/heartjnl-2013-304073","article-title":"Acute catecholamine cardiomyopathy in patients with phaeochromocytoma or functional paraganglioma","volume":"99","author":"Giavarini","year":"2013","journal-title":"Heart"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the working group on endocrine hypertension of the European society of hypertension","volume":"38","author":"Lenders","year":"2020","journal-title":"J Hypertens"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1097\/00004872-200309000-00020","article-title":"Diabetes as a marker of pheochromocytoma in hypertensive patients","volume":"21","author":"La Batide-Alanore","year":"2003","journal-title":"J Hypertens"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1124\/pr.56.3.1","article-title":"Catecholamine metabolism: a contemporary view with implications for physiology and medicine","volume":"56","author":"Eisenhofer","year":"2004","journal-title":"Pharmacol Rev"},{"key":"B14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000074656","article-title":"Principles of catecholamine biosynthesis, metabolism and release","volume":"31","author":"Schulz","year":"2004","journal-title":"Front Horm Res"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jhh.1001334","article-title":"Dopamine, hypertension and obesity","author":"Contreras","year":"2002","journal-title":"J Hum Hypertens"},{"key":"B16","first-page":"1","article-title":"Cardiovascular and renal actions of dopamine: potential clinical applications","volume":"24","author":"Goldberg","year":"1972","journal-title":"Pharmacol Rev"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1159\/000073676","article-title":"Regulation of blood pressure by dopamine receptors","volume":"95","author":"Jose","year":"2003","journal-title":"Nephron Physiol"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2019.04.047","article-title":"The pharmacology of alpha(1)-adrenoceptor subtypes","volume":"855","author":"Docherty","year":"2019","journal-title":"Eur J Pharmacol"},{"key":"B19","article-title":"Adrenergic and muscarinic receptors in the human heart","volume":"51","author":"Brodde","year":"1999","journal-title":"Pharmacol Rev"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v7.i4.204","article-title":"Autonomic and endocrine control of cardiovascular function","volume":"7","author":"Gordan","year":"2015","journal-title":"World J Cardiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2344\/0003-3006-62.1.31","article-title":"Alpha-2 adrenergic receptor agonists: a review of current clinical applications","volume":"62","author":"Giovannitti","year":"2015","journal-title":"Anesth Prog"},{"key":"B22","doi-asserted-by":"publisher","first-page":"690","DOI":"10.4158\/EP161718.RA","article-title":"Precision medicine: an update on Genotype\/Biochemical phenotype relationships in Pheochromocytoma\/Paraganglioma patients","volume":"23","author":"Gupta","year":"2017","journal-title":"Endocr Pract"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2007-1720","article-title":"Preoperative management of the pheochromocytoma patient","volume":"92","author":"Pacak","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.90591.2008","article-title":"Differential expression of the regulated catecholamine secretory pathway in different hereditary forms of pheochromocytoma","volume":"295","author":"Eisenhofer","year":"2008","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-12_part_1-200506210-00023","article-title":"A new concept of unopposed beta-adrenergic overstimulation in a patient with pheochromocytoma","volume":"142","author":"Kantorovich","year":"2005","journal-title":"Ann Intern Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.1992.tb02326.x","article-title":"Phaeochromocytomas as a cause of hypotension","volume":"37","author":"Baxter","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B27","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/s0022-2828(85)80130-9","article-title":"Catecholamine cardiotoxicity","volume":"17","author":"Rona","year":"1985","journal-title":"J Mol Cell Cardiol"},{"key":"B28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1056\/NEJM198207013070104","article-title":"Adrenergic receptors in man: direct identification, physiologic regulation, and clinical alterations","volume":"307","author":"Motulsky","year":"1982","journal-title":"N Engl J Med"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/0304-4165(78)90193-9","article-title":"Hormone action at the membrane level. viii. adrenergic receptors in rat heart and adipocytes and their modulation by thyroxine","volume":"541","author":"Ciaraldi","year":"1978","journal-title":"Biochim Biophys Acta"},{"key":"B30","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1097\/00000441-197107000-00002","article-title":"The role of catecholamines in producing arrhythmias","volume":"262","author":"Leon","year":"1971","journal-title":"Am J Med Sci"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.2174\/092986711795656081","article-title":"Contribution of catecholamine reactive intermediates and oxidative stress to the pathologic features of heart diseases","volume":"18","author":"Costa","year":"2011","journal-title":"Curr Med Chem"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043046","article-title":"Neurohumoral features of myocardial stunning due to sudden emotional stress","volume":"352","author":"Wittstein","year":"2005","journal-title":"N Engl J Med"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-012-1079-x","article-title":"Mitochondria play a central role in nonischemic cardiomyocyte necrosis: common to acute and chronic stressor states","volume":"464","author":"Khan","year":"2012","journal-title":"Pflugers Arch"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1006\/jmcc.2000.1285","article-title":"Reactive oxygen species mediate alpha-adrenergic receptor-stimulated hypertrophy in adult rat ventricular myocytes","volume":"33","author":"Amin","year":"2001","journal-title":"J Mol Cell Cardiol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.118.313416","article-title":"Formation of aminochrome leads to cardiac dysfunction and sudden cardiac death","volume":"123","author":"Dhalla","year":"2018","journal-title":"Circ Res"},{"key":"B36","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/BF00421086","article-title":"Measurement of adrenolutin as an oxidation product of catecholamines in plasma","volume":"87","author":"Dhalla","year":"1989","journal-title":"Mol Cell Biochem"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2828(75)90132-7","article-title":"Induction of necrosis and failure in the isolated perfused rat heart with oxidized isoproterenol","volume":"7","author":"Yates","year":"1975","journal-title":"J Mol Cell Cardiol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-8703(81)80012-9","article-title":"Ventricular dysfunction and necrosis produced by adrenochrome metabolite of epinephrine: relation to pathogenesis of catecholamine cardiomyopathy","volume":"102","author":"Yates","year":"1981","journal-title":"Am Heart J"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.4158\/EP.14.9.1137","article-title":"Catecholamine-induced cardiomyopathy","volume":"14","author":"Kassim","year":"2008","journal-title":"Endocr Pract"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.31083\/j.rcm2204130","article-title":"Catecholamine-induced cardiomyopathy: an endocrinologist's perspective","volume":"22","author":"Kumar","year":"2021","journal-title":"Rev Cardiovasc Med"},{"key":"B41","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1161\/CIRCULATIONAHA.112.111591","article-title":"High levels of circulating epinephrine trigger apical cardiodepression in a Beta2-adrenergic Receptor\/Gi-dependent manner: a new model of takotsubo cardiomyopathy","volume":"126","author":"Paur","year":"2012","journal-title":"Circulation"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.021428","article-title":"Agonist dose-dependent phosphorylation by protein kinase a and G protein-coupled receptor kinase regulates Beta2 adrenoceptor coupling to G(I) proteins in cardiomyocytes","volume":"284","author":"Liu","year":"2009","journal-title":"J Biol Chem"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1093\/eurjhf\/hfp173","article-title":"L41q polymorphism of the G protein coupled receptor kinase 5 is associated with left ventricular apical ballooning syndrome","volume":"12","author":"Spinelli","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.853878","article-title":"Predictive factors for catecholamine-induced cardiomyopathy in patients with pheochromocytoma and paraganglioma","volume":"13","author":"Wang","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.877341","article-title":"Risk factors for cardiac complications in patients with pheochromocytoma and paraganglioma: a retrospective single-center study","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1007\/s002100000339","article-title":"Dopamine receptors in human platelets","volume":"363","author":"Ricci","year":"2001","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2362.1996.150293.x","article-title":"Role of catecholamines in platelet function: pathophysiological and clinical significance","volume":"26","author":"Anfossi","year":"1996","journal-title":"Eur J Clin Invest"},{"key":"B48","doi-asserted-by":"publisher","first-page":"R80","DOI":"10.1186\/cc6931","article-title":"In vitro norepinephrine significantly activates isolated platelets from healthy volunteers and critically ill patients following severe traumatic brain injury","volume":"12","author":"Tschuor","year":"2008","journal-title":"Crit Care"},{"key":"B49","doi-asserted-by":"publisher","first-page":"7560","DOI":"10.3390\/ijms21207560","article-title":"Depression and cardiovascular disease: the viewpoint of platelets","volume":"21","author":"Amadio","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/s0049-3848(01)00237-7","article-title":"Endothelial dysfunction, nitric oxide and platelet activation in hypertensive and diabetic type ii patients","volume":"102","author":"Ouvina","year":"2001","journal-title":"Thromb Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1001\/jama.287.19.2570","article-title":"Diabetes and atherosclerosis: epidemiology, pathophysiology, and management","volume":"287","author":"Beckman","year":"2002","journal-title":"JAMA"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-21-0373","article-title":"Genetic biomarkers of life-threatening pheochromocytoma-induced cardiomyopathy","volume":"29","author":"Amar","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjcard.2016.03.019","article-title":"Clinical features and outcome of pheochromocytoma-induced takotsubo syndrome: analysis of 80 published cases","volume":"117","author":"YH","year":"2016","journal-title":"Am J Cardiol"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-019-02035-3","article-title":"Pheochromocytoma- and paraganglioma-triggered takotsubo syndrome","volume":"65","author":"YH","year":"2019","journal-title":"Endocrine"},{"key":"B55","article-title":"[Myocardial stunning due to simultaneous multivessel coronary spasms: a review of 5 cases]","volume":"21","author":"Dote","year":"1991","journal-title":"J Cardiol"},{"key":"B56","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s10286-017-0465-z","article-title":"Epidemiology, pathogenesis, and management of takotsubo syndrome","volume":"28","author":"YH","year":"2018","journal-title":"Clin Auton Res"},{"key":"B57","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2016.11.086","article-title":"Contemporary review on the pathogenesis of takotsubo syndrome: the heart shedding tears: norepinephrine churn and foam at the cardiac sympathetic nerve terminals","volume":"228","author":"YH","year":"2017","journal-title":"Int J Cardiol"},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.4158\/EP171930.OR","article-title":"Takotsubo-like cardiomyopathy in a Large cohort of patients with pheochromocytoma and paraganglioma","volume":"23","author":"Gagnon","year":"2017","journal-title":"Endocr Pract"},{"key":"B59","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehy077","article-title":"International expert consensus document on takotsubo syndrome (Part ii): diagnostic workup, outcome, and management","volume":"39","author":"Ghadri","year":"2018","journal-title":"Eur Heart J"},{"key":"B60","doi-asserted-by":"publisher","DOI":"10.2169\/internalmedicine.54.4732","article-title":"Ventricular rhythm and hypotension in a patient with pheochromocytoma-induced myocardial damage and reverse takotsubo cardiomyopathy","volume":"54","author":"Tagawa","year":"2015","journal-title":"Intern Med"},{"key":"B61","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1093\/eurheartj\/ehm449","article-title":"Inverted takotsubo cardiomyopathy due to pheochromocytoma","volume":"29","author":"Di Valentino","year":"2008","journal-title":"Eur Heart J"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23352","article-title":"Clinical features, complications, and outcomes of exogenous and endogenous catecholamine-triggered takotsubo syndrome: a systematic review and meta-analysis of 156 published cases","volume":"43","author":"YH","year":"2020","journal-title":"Clin Cardiol"},{"key":"B63","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.jacc.2021.11.021","article-title":"Management of hypertrophic cardiomyopathy: jacc state-of-the-Art review","volume":"79","author":"Maron","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"B64","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2021.0944","article-title":"Pheochromocytoma presenting as hypertrophic obstructive cardiomyopathy","volume":"6","author":"Wani","year":"2021","journal-title":"JAMA Cardiol"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1093\/ajh\/hpaa126","article-title":"A case of late-detected pheochromocytoma in a young patient with resistant hypertension and hypertrophic cardiomyopathy","author":"Alamri","year":"2020","journal-title":"Am J Hypertens"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.1177\/000331979404501113","article-title":"Pheochromocytoma with echocardiographic features of obstructive hypertrophic cardiomyopathy. a case report","volume":"45","author":"Jacob","year":"1994","journal-title":"Angiology"},{"key":"B67","doi-asserted-by":"publisher","DOI":"10.1378\/chest.109.5.1394","article-title":"Pheochromocytoma associated with clinical and echocardiographic features simulating hypertrophic obstructive cardiomyopathy","volume":"109","author":"Huddle","year":"1996","journal-title":"Chest"},{"key":"B68","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcmg.2020.07.017","article-title":"Left ventricular structural and functional alterations in patients with Pheochromocytoma\/Paraganglioma before and after surgery","volume":"13","author":"Dobrowolski","year":"2020","journal-title":"JACC Cardiovasc Imaging"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1530\/ERP-19-0026","article-title":"Echocardiographic global longitudinal strain is associated with infarct size assessed by cardiac magnetic resonance in acute myocardial infarction","volume":"6","author":"Joseph","year":"2019","journal-title":"Echo Res Pract"},{"key":"B70","doi-asserted-by":"publisher","first-page":"333\u2013340","DOI":"10.1093\/ajh\/hpad006","article-title":"Targeting left ventricular mechanics in patients with Pheochromocytoma\/Paraganglioma: an updated meta-analysis","volume":"36","author":"Cuspidi","year":"2023","journal-title":"Am J Hypertens"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e32834a4ce9","article-title":"Cardiovascular manifestations of phaeochromocytoma","volume":"29","author":"Prejbisz","year":"2011","journal-title":"J Hypertens"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcard.2017.07.014","article-title":"Pheochromocytoma as a reversible cause of cardiomyopathy: analysis and review of the literature","volume":"249","author":"Zhang","year":"2017","journal-title":"Int J Cardiol"},{"key":"B73","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1038\/s41572-019-0084-1","article-title":"Dilated cardiomyopathy","volume":"5","author":"Schultheiss","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1055\/s-0035-1555913","article-title":"The emerging role of cardiovascular magnetic resonance imaging in the evaluation of metabolic cardiomyopathies","volume":"47","author":"Mavrogeni","year":"2015","journal-title":"Horm Metab Res"},{"key":"B75","article-title":"Heart transplantation for end-stage cardiomyopathy caused by an occult pheochromocytoma","volume":"11","author":"Wilkenfeld","year":"1992","journal-title":"J Heart Lung Transplant"},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1016\/s1053-2498(00)00233-3","article-title":"Pheochromocytoma presenting after cardiac transplantation for dilated cardiomyopathy","volume":"20","author":"Dalby","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-002-6667-z","article-title":"Efficacy and safety of doxazosin for perioperative management of patients with pheochromocytoma","volume":"26","author":"Prys-Roberts","year":"2002","journal-title":"World J Surg"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz188","article-title":"Efficacy of alpha-blockers on hemodynamic control during pheochromocytoma resection: a randomized controlled trial","volume":"105","author":"Buitenwerf","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgab130","article-title":"The role for metyrosine in the treatment of patients with pheochromocytoma and paraganglioma","volume":"106","author":"Gruber","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehu284","article-title":"ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the task force for the diagnosis and management of hypertrophic cardiomyopathy of the European society of cardiology (ESC)","volume":"35","author":"PM","year":"2014","journal-title":"Eur Heart J"},{"key":"B82","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1186\/s12872-022-02913-1","article-title":"Von Hippel-lindau syndrome with a rare complication of dilated cardiomyopathy: a case report","volume":"22","author":"Yu","year":"2022","journal-title":"BMC Cardiovasc Disord"},{"key":"B83","article-title":"The cardioprotective effect of the sodium-glucose cotransporter 2 inhibitor dapagliflozin in rats with isoproterenol-induced cardiomyopathy","volume":"13","author":"Wang","year":"2021","journal-title":"Am J Transl Res"},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvac004","article-title":"Perioperative management of pheochromocytomas and sympathetic paragangliomas","volume":"6","author":"Fagundes","year":"2022","journal-title":"J Endocr Soc"},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.1530\/EDM-17-0122","article-title":"Management of an acute catecholamine-induced cardiomyopathy and circulatory collapse: a multidisciplinary approach","volume":"2017","author":"Casey","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1097\/ALN.0b013e31816c8a78","article-title":"Extracorporeal cardiopulmonary support for cardiogenic shock caused by pheochromocytoma: a case report and literature review","volume":"108","author":"Grasselli","year":"2008","journal-title":"Anesthesiology"},{"key":"B87","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcr\/ytaa513","article-title":"A rare pheochromocytoma complicated by cardiogenic shock and posterior reversible encephalopathy syndrome: case report","volume":"5","author":"Dominedo","year":"2021","journal-title":"Eur Heart J Case Rep"},{"key":"B88","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.60.700.111","article-title":"Phaeochromocytoma and acute cardiovascular death (with special reference to myocardial infarction)","volume":"60","author":"Cohen","year":"1984","journal-title":"Postgrad Med J"},{"key":"B89","doi-asserted-by":"publisher","DOI":"10.1177\/0267659120908413","article-title":"Extracorporeal life support for phaeochromocytoma-induced cardiogenic shock: a systematic review","volume":"35","author":"Matteucci","year":"2020","journal-title":"Perfusion"},{"key":"B90","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3390\/jcdd9030071","article-title":"Successful management of pheochromocytoma crisis with cardiogenic shock by percutaneous left ventricular assist device","volume":"9","author":"Nakamura","year":"2022","journal-title":"J Cardiovasc Dev Dis"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.37616\/2212-5043.1026","article-title":"Perioperative management of pheochromocytoma resection in a patient with a continuous flow left ventricular assist device","volume":"32","author":"Albulushi","year":"2020","journal-title":"J Saudi Heart Assoc"},{"key":"B92","doi-asserted-by":"publisher","DOI":"10.1038\/nrcardio.2009.58","article-title":"Mechanical bridge to recovery in pheochromocytoma myocarditis","volume":"6","author":"Westaby","year":"2009","journal-title":"Nat Rev Cardiol"},{"key":"B93","doi-asserted-by":"publisher","DOI":"10.1097\/01.mej.0000134729.95226.e7","article-title":"The paradox of hypotension and pheochromocytoma: a case report","volume":"11","author":"De Wilde","year":"2004","journal-title":"Eur J Emerg Med"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1204851\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T15:45:28Z","timestamp":1689263128000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1204851\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,13]]},"references-count":93,"alternative-id":["10.3389\/fendo.2023.1204851"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1204851","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,13]]},"article-number":"1204851"}}